Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Studying the club drug could bring about faster-acting and more-effective treatments.
A recently discovered cell survival switch could be key to increasing longevity.
Compounds that trigger the growth of new brain cells might help treat depression.
Researchers hope that curcumin encapsulated in nanospheres will spice up clinical trials for Alzheimer’s, cystic fibrosis, and cancer.
Electrodes implanted in the brain show promise in early trials.
Neurologists urge caution upon reports of a successful therapy.
When he learned in 1995 that he had Alzheimer’s disease, William Utermohlen, an American artist living in London, immediately began work on an ambitious series of self-portraits.
In an experimental trial, surgeons have implanted deep-brain stimulators into U.S. and Canadian Alzheimer’s patients.
Drugs in development could treat the cognitive deficits caused by Alzheimer’s.
A compound that helps memory recall in brain-damaged mice could pave the way for new drugs to treat dementia.